Back to top

Senior Director, Global Contract Manufacturing – Top 10 Global Pharmaceutical

Retained by a top 10 global pharmaceutical company to deliver a key senior director for their growing external manufacturing business. The challenge was around the mix of experience required which included detailed knowledge of manufacturing technologies across multiple verticals including sterile and non-sterile drug substance and drug product, OSD, Respiratory and API manufacturing. Project was completed successfully within a 12 week period.

Country Medical Director – Top 5 Global Pharma

Managed a successful search and selection exercise for a top 5 global Pharmaceutical group who were having significant issues finding a suitably qualified Medical Director for the country of Ireland in a very tight marketplace. The brief was completed within the specified 12 week time-frame agreed with the group.

Global QA Head – Speciality International Pharma

Led a successful search campaign to select a Senior Vice President and Global Head of Quality for a US based bio-pharmaceutical group. The role was to be based in Dublin and required experience with managing very significant global clinical and R&D operations as well GMP and commercial quality affairs. A challenging brief due to the paucity of research and development in Ireland. Brief completed on time and within salary range.

General Manager, EU – Rare Disease Speciality Biotechnology

Approached by a rapidly expanding US based Orphan Drug Biotechnology start-up. The company was seeking to establish their EU operations and required a General Manager with a fundamental grasp of EU Market Access strategies for the launch of specific rare disease therapies in multiple geographies. The search was successfully completed within an 8 week period.

Head of EU Regulatory Affairs – US Biotechnology Start-Up

Retained by a US based, clinical stage biotechnology company who required a Senior Regulatory and CMC Director to be based in Europe. The company’s main product had successfully achieved phase II approvals and they were looking to commercialize in the EU. The experiences required included taking a clinical product from Phase II onwards into commercialization. Assigned brief was successfully completed within the defined 12 week period.

"The whole of science is nothing more than a refinement of everyday thinking." Albert Einstein